Effect of chronic hypocortisolaemia on plasma cortisol concentrations during intravenous infusions of Hydrocortisone sodium succinate (cas 125-04-2) in dogs
-
Add time:09/27/2019 Source:sciencedirect.com
Intravenous infusions of Hydrocortisone sodium succinate (cas 125-04-2) (HSS) were given at 0·625 mg kg−1 hour−1 and 0·312 mg kg−1 hour−1 to six dogs. Plasma cortisol concentrations were measured by radioimmunoassay at 0, 15, 30, 45 and 60 minutes and then every 30 minutes for a further five hours. Chronic hypocortisolaemia was induced and maintained with mitotane and the HSS infusions were repeated after 31 and 50 days. No statistically significant difference was observed in the plasma cortisol concentrations after either period of hypocortisolaemia, but the plasma cortisol concentrations tended to be higher in most of the dogs.
We also recommend Trading Suppliers and Manufacturers of Hydrocortisone sodium succinate (cas 125-04-2). Pls Click Website Link as below: cas 125-04-2 suppliers
Prev:Perioperative hydrocortisone treatment reduces postoperative pancreatic fistula rate after open distal pancreatectomy. A randomized placebo-controlled trial
Next:Original articleBronchospasm caused by intravenous Hydrocortisone sodium succinate (cas 125-04-2) (Solu-Cortef) in aspirin-sensitive asthmatics) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Original articleBronchospasm caused by intravenous Hydrocortisone sodium succinate (cas 125-04-2) (Solu-Cortef) in aspirin-sensitive asthmatics10/01/2019
- Perioperative hydrocortisone treatment reduces postoperative pancreatic fistula rate after open distal pancreatectomy. A randomized placebo-controlled trial09/26/2019
- Original articleMolecular and cytogenetic evaluation for potential genotoxicity of hydrocortisone09/25/2019
- Short CommunicationHydrocortisone relieves the immediate post-operative scrotal edema after inguinal varicocelectomy: A prospective clinical trial09/24/2019
- Hydrocortisone sodium succinate (cas 125-04-2) does not cross-react with aspirin in aspirin-sensitive patients with asthma☆☆☆★09/10/2019
- Controlled intraoral delivery of Hydrocortisone sodium succinate (cas 125-04-2)09/09/2019
- Short communicationShelf lives of aseptically prepared medicines – stability of Hydrocortisone sodium succinate (cas 125-04-2) in PVC and non-PVC bags and in polypropylene syringes09/08/2019
-
Health and Chemical more >
-
Related Products
- Hydrocortisone 21-hemisuccinate
- Hydrocortisone acetate
- Hydrocortisone buteprate
- Hydrocortisone sodium phosphate
- Hydrocortisone sodium succinate
- Sodium 2,4-dimethylbenzenesulfonate
- SODIUM γ-FLUORO-β-HYDROXYBUTYRATE
- Sodium ((3-methoxy-1-methyl-3-oxo-1-propenyl)amino)phenylacetate
- Sodium (+)-10-camphorsulfonate
- Sodium (2-carbamoylphenoxy)acetate